Top Institutions in Endocrinology and Pancreatic Neuroendocrine Tumors
Leading institutions employ advanced molecular biology techniques including transcriptomics, single-cell RNA sequencing, immunohistochemistry, and patient-derived organoid models to study tumor heterogeneity and functional activity in insulinomas.
-
#1
Mayo Clinic
Rochester, MN
Mayo Clinic is a leader in pancreatic neuroendocrine tumor research and clinical care, with extensive experience in molecular diagnostics and development of organoid models for translational research.
Key Differentiators
- Endocrinology
- Oncology
- Pancreatic Surgery
- Molecular Pathology
-
#2
Johns Hopkins University
Baltimore, MD
Johns Hopkins has a strong focus on neuroendocrine tumor genomics and functional studies, contributing significantly to understanding tumor heterogeneity and molecular pathways involved in insulin secretion.
Key Differentiators
- Endocrinology
- Oncology
- Molecular Genetics
-
#3
Dana-Farber Cancer Institute
Boston, MA
Dana-Farber integrates cutting-edge molecular research with clinical oncology, focusing on novel diagnostic markers and therapeutic targets in neuroendocrine tumors including insulinomas.
Key Differentiators
- Oncology
- Endocrinology
- Translational Research
-
#4
University of California, San Francisco (UCSF)
San Francisco, CA
UCSF has a robust program in pancreatic neuroendocrine tumor research, emphasizing molecular diagnostics and functional imaging to improve clinical management of insulinomas.
Key Differentiators
- Endocrinology
- Surgical Oncology
- Molecular Biology
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Newsletters
Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.
